跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 53 条关于
“YAQ002”
全部
53
临床试验
26
药物
15
机构
0
资讯
12
去年
Yaqrit Secures £2.2 Million NIHR Grant for Pivotal DIALIVE Liver Support Device Trials
8个月前
Marea Therapeutics Reports Positive Phase 1 Results for MAR002 Acromegaly Treatment
去年
Variant Secures EMA Endorsement for VAR002 Gene Therapy Targeting Inherited Retinal Dystrophies
2个月前
First Patient Treated in Phase 2 A-TANGO Trial Evaluating Yaqrit's TLR4 Antagonist YAQ005 for Acute-on-Chronic Liver Failure
去年
Alzheimer's Trials of Simufilam and AL002 Fail to Meet Endpoints
去年
Alector's AL002 Fails to Meet Primary Endpoint in Phase 2 Alzheimer's Trial
去年
Alector and AbbVie's AL002 Fails Phase II Alzheimer's Trial, Leading to Layoffs
去年
Marea Therapeutics' MAR001 Shows Promise in Phase 2a Trial for Cardiovascular Disease; MAR002 for Acromegaly Advances
2年前
Alector Presents Baseline Data from INVOKE-2 Phase 2 Trial of AL002 for Early Alzheimer's Disease
2个月前
Phase 1b Trial Shows Short-Lived Anti-PD-L1 Antibody IBC-Ab002 Is Well Tolerated in Early Alzheimer's Disease
第 1 页,共 2 页
上一页
下一页